Vimarsana
Biggest News Aggregation in the World

Page 34 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cassava Sciences Today - Breaking & Trending Today

Cassava Sciences : Corporate Presentation – August 2023 -Today at 12:48 pm - Vimarsana News

Cassava Sciences : Corporate Presentation – August 2023 -Today at 12:48 pm

Our Focus is Alzheimer's disease August 2023 Forward-Looking Statements & Safe...

Cassava Sciences (NASDAQ:SAVA) Hits New 1-Year Low at $17.70 - Vimarsana News

Cassava Sciences (NASDAQ:SAVA) Hits New 1-Year Low at $17.70

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as $17.70 and last traded at $17.87, with a volume of 44589 shares traded. The stock had previously closed at $17.92. Wall Street Analyst Weigh In Separately, HC Wainwright reaffirmed a “buy” rating […]

Stocks That Hit 52-Week Lows On Friday - NeuBase Therapeutics (NASDAQ:NBSE), Mullen Automotive (NASDAQ:MULN) - Vimarsana News

Stocks That Hit 52-Week Lows On Friday - NeuBase Therapeutics (NASDAQ:NBSE), Mullen Automotive (NASDAQ:MULN)

  During the Friday's sesion, 157 stocks hit new 52-week lows.

Cassava Sciences Stock (NASDAQ:SAVA), Quotes and News Summary - Vimarsana News

Cassava Sciences Stock (NASDAQ:SAVA), Quotes and News Summary

Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.

Baystreet.ca - Cassava Out with Q2 Figures - Vimarsana News

Baystreet.ca - Cassava Out with Q2 Figures

Cassava Sciences, Inc. (NASDAQ: SAVA) saw its shares descend Thursday, as the clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the second quarter ended June 30, 2023. Net loss was $26.4 million, ...